anti-Goat Anti-human IgA/FITC抗體  瑞齊生物抗體應用于WB、IHC、IF、ELISA等實驗中“

anti-Goat Anti-human IgA/FITC抗體 ”，*，提供完善的售前、售中、售后服務！

   咨詢或在線客服！我們將竭誠為您服務！在，我們堅持對產品質量作不斷的評估、創新和改善以確保您對我們產品的高度信任。

上海瑞齊生物科技有限公司，致力為廣大科研人士提供質優價美的科研產品，產品質量保證，提供，有任何質量問題可免費包退包換，咨詢！更多產品請點擊此處查看<<<<<<<

【產品規格】：0.1ml/0.2ml
【產品價格】：詢價（電詢或客服）
【抗體來源】：Rabbit OR Mouse or Goat
【產品用途】：科研實驗，用于ELISA實驗、免疫組化實驗，WB實驗，IF實驗等，可，索取產品說明書！
【性    狀】： Lyophilized or Liquid
【濃    度】： 1mg/1ml
【亞    型】： IgG
【貯    存】： 貯存于-20℃.
【相關標記】：HRP  Biotin  Gold  RBITC  AP  FITC  Cy3  Cy5  Cy5.5  Cy7 PE  PE-Cy3  PE-CY5  PE-CY5.5  PE-CY7  APC  Alexa Fluor 350   Alexa Fluor 488    Alexa Fluor 555     Alexa Fluor 647
【產品別名】：

 ，多肽抗原，蛋白抗體Angiotensin II (Ang II) is an important physiological effector of blood pressure and volume regulation through vasoconstriction, aldosterone release, sodium uptake and thirst stimulation. Although Ang II interacts with two types of cell surface receptors, AT1 and AT2, most of the major cardiovascular effects seem to be mediated through AT1. Molecular cloning of the AT1 protein has shown it to be a member of the G protein-associated seven transmembrane protein receptor family. Ang II treatment of cells results in activation of several signal transduction pathways as evidenced by tyrosine phosphorylation of several proteins and induction of others. PLC?is phosphorylated after 30 seconds of treatment with Angiotensin II, indicating this as an early signal transduction event. Ang II treatment also stimulates phosphorylation of Shc, FAK and MAP kinases, and induces MKP-1, indicating stimulation of growth factor pathways. Ang II stimulation through AT1 has been shown to activate the JAK/Stat pathway involving a direct interaction between JAK2 and AT1 as demonstrated by coimmunoprecipitation. The AT1 receptor has no cytoplasmic kinase domain, but is able to function as a substrate for Src kinases and has several putative phosphorylation sites.

 ：產品類似：RS-0757P CDK2 (Cyclin-Dependent Kinase 2)??周期素依賴激酶2(抗原)
RS-0633P CDK4(Cyclin Dependent Kinase 4)??周期素依賴性激酶4(抗原)
RS-0060P CEA??人癌胚抗原
RS-0441P ChRM2 (Muscarinic Acetylcholine receptor M2)??毒蕈堿型乙酰膽堿受體M2（抗原）
RS-0651P Connexin-43(Cx43)??間隙連接蛋白43(純化片斷抗原)
RS-0652P Connexin-45(CX45)??間隙連接蛋白45(抗原)
RS-0709P Anti-Collagen II??II 型膠原(抗原)
RS-1009P CXCR1 (CXC-chemokine receptor 1)??細胞表面趨化因子受體1抗原
RS-0732P COX-2 (Prostaglandin-endoperoxide synthase-2)??前列腺素氧化環化酶2(抗原)
RS-0697P c-phycocyanin(C-PC)??C-藻藍素(藻藍蛋白)
RS-0743P CTGF (connective tissue growth factor)??結締組織生長因子(純化抗原)
RS-0573P Cyclin E??周期素E/原癌基因抗原
RS-0497P Dnmt3a(cytosine-5)-methyltransferase 3A)??DNA甲基轉移酶-3α(抗原)
RS-0282P Cyclin C??周期素 C(抗原)
RS-0791P CGRP (calcitonin gene related peptide, CGRP)??降鈣素基因相關肽
RS-0614P CULLIN (Cdc53/CUL)??
RS-0461P CYP450(Cytochrome P450 monooxygenase)??細胞色素P450單氧化酶(純化抗原)
RS-0488P CXorf36(uncharacterized protein Cxorf36 precursor)??脫羧酶蛋白體36 cxorf36抗原
RS-0399P Deltex-1??(DTX1) (Deltex protein 1)抗原
RS-0428P DISC1(disrupted in schizophrenia1)(NT)??DISC1 N端抗原
RS-0430P DISC1(disrupted in schizophrenia1)(CT)??DISC1 C端抗原
RS-0421P DR3/TRAMP (death receptor-3)??DR3 死亡受體（抗原）RS0840 F81 細胞， 貓腎細胞
RS0850 F9 細胞， 小鼠畸胎瘤細胞
RS0860 FaDu 細胞， 人咽鱗癌細胞
RS0870 FO 細胞， 小鼠骨髓瘤細胞
RS0880 FRhK-4 細胞， 恒河猴胚腎細胞
RS0890 GBC-SD 細胞， 人膽囊癌細胞
RS0900 H9c2(2-1) 細胞， 大鼠心肌細胞
RS0910 HA 細胞， 人羊膜細胞
RS0920 HBL-100 細胞， 人整合SV40 基因的乳腺上皮細胞
RS0930 HCC 94 [HCC941122] 細胞， 人子宮鱗癌細胞（高分化）
RS0940 HCC1937細胞， 人乳腺癌細胞
RS0950 HCC827細胞， 人非小細胞肺癌細胞
RS0960 HCCC-9810 細胞， 人膽管細胞型肝癌細胞
RS0970 Hce-8693 細胞， 人盲腸腺癌細胞（未分化）
RS0980 HCT 116 細胞， 人結腸癌細胞
RS0990 HCT-15 細胞， 人結直腸腺癌細胞
RS1000 HCT-8 [HRT-18] 細胞， 人回盲腸癌細胞
RS1010 HEC-1-A細胞， 人子宮內膜腺癌細胞
RS1020 HEC-1-B 細胞， 人子宮內膜腺癌細胞
RS1030 HEL 細胞， 人紅白細胞白血病細胞